2020-03-17
H
H
## 香港3月3日 － 香港生物科技协会(HKBIO)联合多家生物科技公司和药厂，在香港科学园举行新闻发布会，宣布海康生命科技有限公司向社会无偿捐献其自主研发的“ERT- PCR 技术检测新型冠状病毒(SARS-CoV-2)”，供有需要的医疗、科研机构无偿使用，并提供后期技术支持，这项技术向社会免费开放。希望透过这项检测技术，缓解目前疫情防控中普遍存在的检测不准确、假阴性率高、病人长时间等候等难题。
On 3rd March 2020 - Hong Kong Biotechnology Organization (HKBIO) cooperated with various biotechnology and pharmaceutical companies to hold a press conference in Hong Kong Science Technology Parks Corporation, announcing that Hai Kang Life Corporation Limited will be donating its independently developed ‘ERT-PCR technology for SARS-CoV-2 coronavirus testing’ to the community. The ‘ERT-PCR technology for SARS-CoV-2 coronavirus testing’ will be available for free use for all medical and scientific institutions in need, and if required technical support can be provided. By making this technology publicly available, it will be more readily implemented thus, effectively alleviating problems such as inaccurate detection, high false negative rates, and long waiting times for patients.
海康生命科技有限公司主席于常海教授开幕致词时表示：「防控疫情需要及早发现潜在的病毒感染者，从而减少传播给亲属及密切接触者的机会，这就需要有一种灵敏而快速的检测方法。我们把ERT-PCR技术检测无偿奉献社会，就是希望贡献出自己的一份力量，回应社会的关切，和大家一起抗疫，保护社会大众的安全和健康。」
In the opening speech, Hai Kang Life Corporation Limited Chairman Albert Yu said: “Accurate diagnosis of potential viral infections is necessary in effective intervention against infectious outbreaks, and is especially important to reduce chances of transmission. It needs rapid accurate detection. We have donated our ERT-PCR technology, in hopes to provide our own strengths and contribute to the community. We are working towards fighting the new coronavirus epidemic in collaboration with all sectors in the community to protect the safety and health of the public. "
与新型冠状病毒疫情持续两个月的斗争中，各国倾全力来控制疫情，然而全球各地每天依然有新增怀疑和确诊病患，社会上已人人自危，海康生命科技有限公司ERT- PCR技术检测正正切合社会状况，准确性高并可以大量测试。早于2003年沙士肆虐之际，海康生命科技有限公司与黄干亨基金合作，研究出ERT-PCR技术，并成功应用于临床。针对此次新型冠状病毒疫情，海康生命科技有限公司在香港、北京两地同步召开“新型冠状病毒SARS-CoV-2核酸检测”专题研发小组会议，计划在数周之内为社会提供多种测试方法，可用于不同基层测试需求。在有限的资源和紧迫的时间下，海康香港、北京研发团队通力合作，攻克所有技术难关，成功研发出适用于新型冠状病毒的快速检测方法，这项新技术将为防控疫情提供灵敏度更高的测试平台。
In the two-month struggle with the new coronavirus epidemic, multiple countries have made the effort to control this epidemic. However, the spread of the virus continues, with the number of confirmed new cases multiplying every day. Hai Kang Life Corporation Limited’s ERT-PCR technology is most suitable for this situation because the technology is both highly accurate and sensitive, further its ability to analyze a large number samples at one time makes this method of detection effective and efficient. When the outbreak of SARS was at large 17 years ago, Hai Kang Life Corporation Limited with Philip K.H. Wong Foundation’s support developed an enhanced fluorescence real-time PCR (ERT-PCR) technology and successfully applied it in clinical diagnosis. In response to this new coronavirus epidemic, Hai Kang Life Corporation Limited held a special R & D group meeting on "New Coronavirus SARS-CoV-2 Nucleic Acid Detection" in Hong Kong and Beijing, and planned to provide an improved method for detection for public use. Despite the limited resources and urgent timeframe, Hai Kang Life’s Hong Kong and Beijing R & D teams worked together to overcome all technical difficulties and successfully developed a rapid detection method suitable for the new coronavirus, in order to provide a more sensitive and accurate platform to be utilized in prevention and control.
海康生命科技有限公司首席科学家叶朝阳博士带领研发团队成员何耀昌博士和徐舟博士在发布会上详细介绍ERT-PCR检测技术：「我们整个团队有一个共同的信念，贡献自己的全部专业技术和实战经验，在抗战疫情坚守岗位的每一天，付出的每一滴汗水，是为自己、为家人、为社会、为我们共同生活的城市，让我们携手共同做好疫情防控，打赢疫情阻击战。」
Hai Kang Life Cooperation Limited Chief Scientific Officer Dr. Ye Zhaoyang, with R & D team members Dr. Timothy Ho and Dr. Jodie Xu introduced the ERT-PCR technology at the press conference: "Our team has only one aim and that is to focus all our energies into sharing our expertise and experiences to do more for ourselves, family and community in order to win this battle."
问答环节 Q&A 问: ERT-PCR和其他检测技术有什么区别？ 答: ERT-PCR的灵敏度至少比其他方法高十倍。它使用多一组引物来提高特异性，并使用多一轮扩增来提高灵敏度。 Q: What is the difference between ERT-PCR and other detection technologies? A: ERT-PCR is at least ten times more sensitive than other methods. It uses an extra set of primers and an additional round of amplification of the target sequence to increase sensitivity and specificity. 问: ERT-PCR是世界上灵敏度最高的核酸检测方法吗？ 答: ERT-PCR的灵敏度已经处于极限，其精准度可达至一条核酸链就可以检测到。当然，我们仍然需要使用临床样本进行验证。 Q: Is ERT-PCR the most sensitive nucleic acid detection method in the world? A: The sensitivity of ERT-PCR has already reached the highest level of sensitivity, and requires only one copy of the target sequence in order to be detected. We will continue to use clinical samples for validation. 问: 目前的方法可以在一小时内完成，为什么ERT-PCR测试需要3-4小时？成本是多少？答: ERT-PCR需进行多一轮扩增以增加灵敏度，因此需要更多时间。针无两头利，我们需要牺牲时间以换取灵敏度。成本的方面，只考虑试剂费用，每个反应大约需要50港元。 Q: Current methods can be completed in one hour. Why does the ERT-PCR test take 3-4 hours? How much does it cost? A: Compared to the current method ERT-PCR involves an additional round of amplification of the target sequence to increase sensitivity, so it takes more time. Needless to say, we need to sacrifice time in exchange for sensitivity. In terms of cost, considering only the cost of reagents, each reaction is about HK $ 50. 问: 为什么ERT-PCR技术不在市场上？ 答: ERT-PCR是一种非常高灵敏度的方法。通常情况下，常用的RT-PCR就足够了，但目前疫情的情况，我们认为它是检测方法的首选。 Q: Why is ERT-PCR technology not on the market? A: ERT-PCR technology is patented by Hai Kang Life Corporation Limited, we are working on expanding its application in different fields. In general, the commonly used RT-PCR and other methods are sufficient for their particular purposes. However, in the current epidemic situation, we think it should be the first choice as a detection method. 问: 如果新型冠状病毒出现变种，您们能否成功检测？ 答: 要视乎病毒出现变种的序列位置；我们今次针对新冠病毒检测的基因为保守序列，即使出现变种仍有大机会保持相同序列，保留成功检测的可能性。 Q: If the new coronavirus mutates, can you successfully detect it? A: This is dependent on the location of the mutation. The materials used to target COVID-19 are designed from the conserved regions of the sequence which have a low chance of mutating. Therefore, if a new strain of coronavirus emerges, we are most likely able to detect the conserved sequences ensuring the integrity of the technique. Nevertheless, we are confident in any additional approaches needed for precise differentiation. 问: ERT-PCR技术检测如何操作和使用？ 答: 我们准备了操作手册及视频指导，希望为您提供更多帮助。视频指导：https://www.youtube.com/watch?v=fDb4nn4dQsE 如有需求，我们也可向具有相关操作经验的技术人员提供培训。ERT-PCR核酸检测方法由于其较高灵敏度，可以应用于诸如社区或隔离人员筛查和治愈病人出院前的核查。 Q: How is ERT-PCR technology operated and applied? A: We have prepared operation manuals and video guides for the use of ERT-PCR technology. If required, we can provide training to technicians with the relevant operating experience. Due to its high sensitivity, ERT-PCR technology detection can be applied to the general community and medical teams involved in combatting coronavirus for early diagnosis. Video guidance: https://www.youtube.com/watch?v=fDb4nn4dQsE 另外，这次发布会联合黄干亨基金、基因港(香港)生物科技有限公司、李氏大药厂控股有限公司、依纳康科技有限公司、晶准生物科技有限公司及海康生命科技有限公司，各家公司希望运用他们的资源，在新型冠状病毒疫情下为社会出一分力，分别捐赠口罩、酒精搓手液和营养补充剂给有需要人士。 In addition, Hong Kong Biotechnology Organization was joined by other biotech and pharmaceutical companies: Philip K.H. Wong Foundation, GeneHarbor (Hong Kong) Technologies Limited, Lee’s Pharmaceutical Holdings Limited, eNano Health Limited, Cellomics International Limited and Hai Kang Life Corporation Limited, to provide resources against the new coronavirus epidemic by donating masks, alcohol hand rubs, and nutritional supplements to those in need.
物资捐赠总结 黄干亨基金：一万个口罩 李氏大药厂控股有限公司：一万个口罩 基因港(香港)生物科技有限公司：合共价值十五万的艾沐茵（NMN 9000）补充剂 晶准生物科技有限公司：一百支酒精搓手液 Donation summary: Philip K.H. Wong Foundation: 10,000 masks Lee’s Pharmaceutical Holdings Limited: 10,000 masks GeneHarbor (Hong Kong) Technologies Limited: total of HK$ 150,000 worth of their NMN9000 supplement Cellomics International Limited: 100 alcohol-based handrubs 最后，香港生物科技协会（HKBIO）将于2020年8月19至22日举办香港国际生物科技展BIOHK2020，诚邀各位出席香港首个国际级生物科技盛会，此次盛会包含展览会、学术演讲及项目交流会、一对一商机洽谈。 Finally, Hong Kong Biotechnology Organization (HKBIO) will host the first ever Hong Kong International Biotechnology Exhibition BIOHK2020 from August 19 to 22, 2020. We invite you to attend Hong Kong's first international biotechnology convention which includes Exhibitions, Conference and Pitch Sessions, One2One Partnering Program.
展览会：为来自世界各地的参展商提供一个展示其产品和创新的平台，并了解全球生物科技行业和相关领域的领先者的创新发展 Exhibition: Pitch and Connect your company to the international biotech scene and vast China market for trading and collaboration opportunities 学术演讲及项目交流会：提供一个知识论坛，让科研人员和业界从业人员就生物科技和其他相关领域的新挑战、新出现的问题和未来趋势，交流各自的工作和实际发展经验 Conference and Pitch Sessions: Share and Inspire through invaluable discussions about the latest regional and international research findings and industry trends 一对一商机洽谈：帮助与会者以投资者、分析师和合伙公司的形式，联络和确定未来的合作伙伴 One2One Partnering: Promote and Establish your company as ‘one to watch’ in the biotech marketplace by identifying and meeting prospective partners
希望各位可以和我们联系或发送感兴趣和关注的问题，我们的团队将随时为您提供帮助，并期待在2020年8月见到您！ Please contact us or send us questions of interest and concern. Our team will always be here to help you and look forward to seeing you in August 2020! 详情请浏览BIOHK2020官网：www.bio-hk.com 或联络我们 (电邮：info@bio-hk.com | 电话：2799 7688) Visit BIOHK2020 website for more details：www.bio-hk.com or Contact us (Email：info@bio-hk.com | Tel：2799 7688)